IP Library Granted Patent US 12,352,747
Granted Patent B2
US 12,352,747 · App. 17/052,375 · Granted Jul 8, 2025

System for analyzing quantitative lateral flow chromatography

Inventors: Franz Paul Armbruster (Bensheim, DE); Felix Walzer (Bensheim, DE); Ben John (Bensheim, DE)
Assignee: Immundiagnostik AG
G01N33/54388G01N15/0625G01N21/8483G01N15/01G01N2015/0687
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,352,747
App. No.
17/052,375
Granted
Jul 8, 2025
Kind
B2
Abstract

An analyte testing system for quantifying the presence of an analyte in a speciment by lateral flow chromatography. The system comprises a test cassette ( 10 ) with a lateral flow chromatography and a mobile hand-held processor device ( 16 ) comprising a digital camera ( 16 a ), a source of light ( 16 b ) and a processor ( 16 c ), which software and hardware ( 16 c ) are configured to determine automatically the distance between camera and object and the measures of light in the region of interest of the lateral flow chromatography prior any retrieval of image data for further analysis and quantification of the visual signals.

Claims (17)

1. A system for determining the presence and content of an analyte in a test sample subjected to lateral flow chromatography, the system comprising

a test device adapted to house a lateral flow test, wherein said test device further displays one or more reference images and a region of interest of said lateral flow test which bears one or more visible response zones indicating the presence and content of said analyte in said test sample and a control zone, and

a portable processor device comprising a digital camera, a source of light and a processor, wherein said processor is configured to process transient digital images of a video captured by said camera and to represent an analytical result, wherein:

said processor is configured to analyze sequentially a plurality of the transient digital images of the video for the presence of one or more permanent reference images;

said processor is configured upon finding one or more permanent reference images, to determine the distance between the found permanent reference image and the digital camera to determine if the distance is acceptable;

said processor is configured to analyze each transient digital image of the video having said permanent reference image at an acceptable distance for said region of interest; and

said processor is configured to examine each of said regions of interest of each transient digital image of the video having a permanent reference image at an acceptable distance for its measures of light reflected and, if the light reflected is in line with predefined measures, said processor is configured to retrieve and save said transient digital image so that only digital images of the region of interest will be processed and analyzed for the optical intensities of said zones which are based on predefined light conditions.

2. The analyte testing system as claimed in claim 1 , wherein the processor is configured to determine the measures of light with respect to absolute brightness, brightness gradient, areas of dark pixels (shadows) and combinations thereof.

3. The analyte testing system as claimed in claim 1 , wherein the processor is configured to retrieve and record multiple approved transient image data of the region of interest for determining the optical intensities of said visible zones.

4. The analyte testing system as claimed in claim 3 , wherein the recorded digital images of the region of interest are corrected for any degree of error associated with any rotational misalignment or skew of the visible zones prior to determination of the optical intensities of the visible zones.

5. The analyte testing system as claimed in claim 1 , wherein the lateral flow test comprises a predetermined amount of control to achieve a defined control zone independently from the presence and content of the analyte in the test sample.

6. The analyte testing system as claimed in claim 1 , wherein the processor is configured to determine the intensity ratios of the zones from a number of saved images and chooses a median ratio for quantitative analysis of the analyte in the test sample.

7. The analyte testing system as claimed in claim 1 , wherein a displayed reference image contains a machine-readable representation of data which encodes or provides access to characteristic data of the lateral flow test.

8. The analyte testing system as claimed in claim 1 , wherein the portable processor device is configured to exchange data and image data with a remote server.

9. The analyte testing system as claimed in claim 1 , wherein the processor is configured to employ data on sharpness and contrast of a displayed reference image.

10. The analyte testing system as claimed in claim 1 , wherein the processor is configured to employ data on the location of the displayed reference image to identify the location of the region of interest with the visible zones.

11. The analyte testing system as claimed in claim 1 , wherein the test device comprises a lateral flow test adapted for faecal calprotectin, serum calprotectin, vitamin D in blood or serum, luteinizing hormone, follicle stimulating hormone, chorionic gonadotropin, thyroid stimulating hormone, albumin, faecal occult blood, gluten immunogenic peptides, bladder cancer marker, Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium africanum, Helicobacter pylori , Influenza virus A and B, troponin I, Tinea unguium, ferritin, D-dimer, C-reactive protein, group A Streptococcus , group B Streptococcus , genetically modified organisms, allergens present in cereals and products thereof, chickpea and products thereof, peanut and products thereof, hazelnut and products thereof, macadamia and products thereof, mustard and products thereof, soya and products thereof, sesame and products thereof, walnut and products thereof, pistachio and products thereof, lupin and products thereof, celery and products thereof, fish and products thereof, crustaceans and products thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2020
From: ARMBRUSTER, FRANZ PAUL; WALZER, FELIX; JOHN, BEN
To: IMMUNDIAGNOSTIK AG
Reel/Frame 054243/0519 →
Priority Claims (1)
DE 10 2018 110 861.3 · May 7, 2018 · national
Continuity (1)
Related Publication 20210172945A1 · Jun 10, 2021
References Cited (45)
US 4298685A · Parikh et al. · 1981 [cited by applicant]
US 5212063A · Ofenloch-Hähnle et al. · 1993 [cited by applicant]
US 5229073A · Luo et al. · 1993 [cited by applicant]
US 5717778A · Chu et al. · 1998 [cited by applicant]
US 8935007B2 · Kloepfer et al. · 2015 [cited by applicant]
US 9350956B2 · Quilter et al. · 2016 [cited by applicant]
US 9390237B2 · Myers et al. · 2016 [cited by applicant]
US 9756324B1 · Flanagan · 2017 [cited by examiner]
US 20050203353A1 · Ma et al. · 2005 [cited by applicant]
US 20060222567A1 · Kloepfer et al. · 2006 [cited by applicant]
US 20090211345A1 · Nahm et al. · 2009 [cited by applicant]
US 20100254581A1 · Neeser et al. · 2010 [cited by applicant]
US 20140065647A1 · Mamenta · 2014 [cited by applicant]
US 20150031412A1 · Quilter et al. · 2015 [cited by applicant]
US 20150241358A1 · Burg et al. · 2015 [cited by applicant]
US 20150286803A1 · Myers · 2015 [cited by examiner]
US 20150308961A1 · Burg et al. · 2015 [cited by applicant]
US 20170242421A1 · Ghazizadeh · 2017 [cited by examiner]
US 20190086400A1 · Ehrenkranz · 2019 [cited by applicant]
CN 1455242A · 2003 [cited by applicant]
DE 102008028908B3 · 2009 [cited by applicant]
EP 1184666 · 2002 [cited by applicant]
EP 0291194B2 · 2003 [cited by applicant]
EP 1550872A2 · 2005 [cited by applicant]
EP 1605249B1 · 2014 [cited by applicant]
EP 2781910A1 · 2014 [cited by applicant]
EP 2835643A1 · 2015 [cited by applicant]
EP 2927688A1 · 2015 [cited by applicant]
EP 2646809B1 · 2018 [cited by applicant]
EP 3470825A1 · 2019 [cited by applicant]
FR 3028317A1 · 2016 [cited by applicant]
GB 2497750A · 2013 [cited by applicant]
JP 5005743B2 · 2012 [cited by applicant]
WO WO9221975A1 · 1992 [cited by applicant]
WO WO2003058242A2 · 2003 [cited by applicant]
WO WO2004011942A1 · 2004 [cited by applicant]
WO WO2005066624A1 · 2005 [cited by applicant]
WO WO2008049083A2 · 2008 [cited by applicant]
WO WO2013122121A1 · 2013 [cited by applicant]
WO WO2013158504A1 · 2013 [cited by applicant]
WO WO2013158505A1 · 2013 [cited by applicant]
WO WO2014025415A2 · 2014 [cited by applicant]
WO WO2014100715A2 · 2014 [cited by applicant]
WO WO2016166415A1 · 2016 [cited by applicant]
Eletu SD et al. Development of an extended-specificity multiplex immunoassay for detection of [cited by examiner]
Cited By (1)
US 12,584,912